Wegovy is a type of GLP-1 medication specifically approved for weight management
Exclusion criteria included unreliably extracted data, non-English language studies, books, conference papers, case reports, and articles without full text, and non-original articles like reviews and meta-analyses
Additionally, research presented at the American Academy of Orthopaedic Surgeons' 2026 annual meeting raised questions about bone and connective tissue effects in GLP-1 users more broadly
NABL Lab Testing NABL (National Accreditation Board for Testing and Calibration Laboratories) accreditation means the product has been tested by a laboratory whose methods and accuracy have been independently verified
The outsourced team handles the administrative work: submissions, tracking, follow-ups, and appeals
doi:10.1016/0035-9203(90)90127-z 23